What is Woundtech?
Founded in 1999, Woundtech operates at the intersection of healthcare innovation and patient-centric service delivery. By deploying expert care teams directly to patient residences, the company addresses the complexities of chronic wound management through evidence-based protocols and proprietary medical solutions. Their business model is designed to integrate seamlessly with insurance providers, effectively bridging the gap between high-acuity clinical needs and the convenience of home-based treatment. With a track record exceeding 2 million patient encounters, the firm has established itself as a critical partner in reducing healthcare expenditures while simultaneously improving patient outcomes and quality of life metrics.
How much funding has Woundtech raised?
Woundtech has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2016): $40M with participation from Aldrich Capital Partners
Key Investors in Woundtech
Aldrich Capital Partners
Aldrich Capital Partners is a growth equity firm that supports founder-run companies by providing both capital and operational expertise to accelerate scaling efforts.
What's next for Woundtech?
With the support of this major strategic investment, Woundtech is well-positioned to scale its proprietary care delivery platform and expand its footprint within the domestic healthcare market. The company's forward-looking strategy likely involves deepening its integration with national insurance networks and enhancing its digital health infrastructure to better address social drivers of health. As the demand for home-based, specialized medical services continues to rise, Woundtech's focus on evidence-based, personalized care provides a robust foundation for sustained growth and long-term value creation in the evolving value-based care landscape.
See full Woundtech company page
